title: Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.
abstract: To examine the impact of common somatic mutations in prostate cancer (PCa) on androgen receptor (AR) signaling, mouse models were designed to perturb sequentially the AR, ETV1, and PTEN pathways. Mice with "humanized" AR (hAR) alleles that modified AR transcriptional strength by varying polyglutamine tract (Q-tract) length were crossed with mice expressing a prostate-specific, AR-responsive ETV1 transgene (ETV1(Tg)). While hAR allele did not grossly affect ETV1-induced neoplasia, ETV1 strongly antagonized global AR regulation and repressed critical androgen-induced differentiation and tumor suppressor genes, such as Nkx3-1 and Hoxb13. When Pten was varied to determine its impact on disease progression, mice lacking one Pten allele (Pten(+/-) ) developed more frequent prostatic intraepithelial neoplasia (PIN). Yet, only those with the ETV1 transgene progressed to invasive adenocarcinoma. Furthermore, progression was more frequent with the short Q-tract (stronger) AR, suggesting that the AR, ETV1, and PTEN pathways cooperate in aggressive disease. On the Pten(+/-) background, ETV1 had markedly less effect on AR target genes. However, a strong inflammatory gene expression signature, notably upregulation of Cxcl16, was induced by ETV1. Comparison of mouse and human patient data stratified by the presence of E26 transformation-specific ETS fusion genes highlighted additional factors, some not previously associated with prostate cancer but for which targeted therapies are in development for other diseases. In sum, concerted use of these mouse models illuminates the complex interplay of AR, ETV1, and PTEN pathways in pre-cancerous neoplasia and early tumorigenesis, disease stages difficult to analyze in man.
authors: Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
authors: Jake
authors: J
authors: Higgins
authors: Michele
authors: M
authors: Brogley
authors: Nallasivam
authors: N
authors: Palanisamy
authors: Rohit
authors: R
authors: Mehra
authors: Michael M
authors: MM
authors: Ittmann
authors: Jun Z
authors: JZ
authors: Li
authors: Scott A
authors: SA
authors: Tomlins
authors: Diane M
authors: DM
authors: Robins
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D000818:Animals; D004268:DNA-Binding Proteins / Q000235:genetics*; D004195:Disease Models, Animal; D018450:Disease Progression; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D051059:PTEN Phosphohydrolase / Q000235:genetics*; D011230:Precancerous Conditions / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D011467:Prostate / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D011944:Receptors, Androgen / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000502:physiology; D014157:Transcription Factors / Q000235:genetics*; D014161:Transduction, Genetic
chemical_list: C410798:AR protein, human; D004268:DNA-Binding Proteins; C095239:ETV1 protein, human; D011944:Receptors, Androgen; D014157:Transcription Factors; D051059:PTEN Phosphohydrolase
references: Hum Mol Genet. 2008 Jan 1;17(1):98-110
references: 17906287
references: Genes Dev. 2011 Oct 15;25(20):2147-57
references: 22012618
references: Cancer Cell. 2010 May 18;17(5):443-54
references: 20478527
references: Genesis. 2002 Feb;32(2):148-9
references: 11857804
references: Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2027-31
references: 24925673
references: Nat Commun. 2013;4:1795
references: 23653207
references: Endocr Relat Cancer. 2009 Jun;16(2):381-9
references: 19369485
references: Prostate Cancer Prostatic Dis. 2013 Jun;16(2):209-15
references: 23545904
references: Cancer Res. 2003 Jul 15;63(14):3886-90
references: 12873978
references: Genes Dev. 2010 Sep 15;24(18):1967-2000
references: 20844012
references: Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):811-6
references: 14711987
references: J Pharmacol Exp Ther. 2011 Aug;338(2):528-36
references: 21602424
references: Nucleic Acids Res. 1994 Aug 11;22(15):3181-6
references: 8065934
references: Cancer Cell. 2011 Jun 14;19(6):792-804
references: 21620777
references: Oncotarget. 2014 Mar 15;5(5):1352-62
references: 24657880
references: PLoS Biol. 2003 Dec;1(3):E59
references: 14691534
references: J Biol Chem. 2005 Oct 28;280(43):36442-51
references: 16055444
references: Prostate. 2006 Jun 15;66(9):895-902
references: 16496415
references: Nat Genet. 2010 May;42(5):454-8
references: 20400965
references: FEBS J. 2014 Aug;281(16):3766-75
references: 24988946
references: Mol Cell Endocrinol. 2011 Aug 6;342(1-2):81-6
references: 21664242
references: Nat Genet. 2009 May;41(5):619-24
references: 19396168
references: Genes Dev. 2000 Oct 1;14(19):2410-34
references: 11018010
references: Cancer Res. 2004 Mar 15;64(6):2270-305
references: 15026373
references: Cell. 1998 Oct 2;95(1):29-39
references: 9778245
references: Prostate. 2014 May;74(6):647-58
references: 24435928
references: Cancer Res. 2013 May 1;73(9):2718-36
references: 23610450
references: Nat Genet. 2009 May;41(5):524-6
references: 19396167
references: Nat Protoc. 2013 Sep;8(9):1765-86
references: 23975260
references: Appl Immunohistochem Mol Morphol. 2015 May-Jun;23(5):364-73
references: 25265431
references: Anat Rec (Hoboken). 2012 Dec;295(12):2114-21
references: 22961798
references: Eur J Med Res. 2013;18:56
references: 24330823
references: J Clin Oncol. 2011 Sep 20;29(27):3659-68
references: 21859993
references: Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):183-8
references: 12518064
references: Neoplasia. 2007 May;9(5):443-54
references: 17534450
references: Hum Mol Genet. 2005 Feb 15;14(4):475-82
references: 15615770
references: Cancer Res. 2006 Nov 15;66(22):11077-83
references: 17108148
references: Dev Biol. 2004 Sep 15;273(2):175-84
references: 15328005
references: Cancer Res. 2010 Dec 1;70(23):9544-8
references: 20947519
references: Neoplasia. 2004 Jan-Feb;6(1):1-6
references: 15068665
references: BMC Cancer. 2012;12:543
references: 23171135
references: BJU Int. 2011 Feb;107(3):477-85
references: 20590547
references: BMC Cancer. 2012;12:382
references: 22938721
references: Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5246-50
references: 9560261
references: J Pharmacol Sci. 2009 Jan;109(1):148-51
references: 19129683
references: Science. 2002 Feb 1;295(5556):868-72
references: 11786607
references: Genome Biol. 2013;14(4):R36
references: 23618408
references: Nature. 2012 Jul 12;487(7406):239-43
references: 22722839
references: J Clin Oncol. 2004 Jul 15;22(14):2790-9
references: 15254046
references: Prostate. 2006 Dec 1;66(16):1729-43
references: 16998812
references: Mod Pathol. 2013 Jun;26(6):835-48
references: 23348902
references: Cancer Cell. 2010 Jul 13;18(1):11-22
references: 20579941
references: Nat Med. 2013 Aug;19(8):1023-9
references: 23817021
references: Cancer Res. 2007 Sep 1;67(17):7991-5
references: 17804708
references: PLoS One. 2008;3(5):e2318
references: 18846227
references: Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):e32-40
references: 25203299
references: Am J Pathol. 2014 Oct;184(10):2598-607
references: 25088980
references: Nature. 2009 Sep 24;461(7263):495-500
references: 19741607
references: Nature. 2007 Aug 2;448(7153):595-9
references: 17671502
references: Lab Invest. 2011 Mar;91(3):404-12
references: 20975660
references: Genes Dev. 2013 Mar 15;27(6):683-98
references: 23512661
references: Cancer Res. 2009 Jun 15;69(12):4937-40
references: 19509232
references: Oncogene. 2015 Jul;34(29):3815-25
references: 25263440
references: Mol Endocrinol. 2003 Aug;17(8):1484-507
references: 12750453
references: Prostate. 2005 Mar 1;62(4):322-38
references: 15389779
references: PLoS One. 2013;8(11):e81702
references: 24260584
references: Am J Pathol. 2004 Jan;164(1):217-27
references: 14695335
references: Neoplasia. 2008 Feb;10(2):177-88
references: 18283340
references: Cancer Res. 2009 May 15;69(10):4434-42
references: 19366804
references: Nat Protoc. 2009;4(1):44-57
references: 19131956
references: Mol Endocrinol. 2006 Jun;20(6):1248-60
references: 16601069
references: Int J Oncol. 2009 Jul;35(1):205-11
references: 19513569
references: Cancer Res. 2002 Jun 1;62(11):2999-3004
references: 12036903
references: Hepatogastroenterology. 2008 Nov-Dec;55(88):2039-44
references: 19260473
references: Genome Biol. 2002 Jun 14;3(7):RESEARCH0032
references: 12184806
references: Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):596-604
references: 15767336
references: Science. 2005 Oct 28;310(5748):644-8
references: 16254181
references: Cancer Cell. 2011 May 17;19(5):575-86
references: 21575859
references: Cell. 2012 Nov 21;151(5):1068-82
references: 23142051
references: J Clin Invest. 2012 Jun;122(6):2092-103
references: 22565310
references: Gut. 2012 Mar;61(3):392-401
references: 21708825
references: Expert Rev Endocrinol Metab. 2011 May;6(3):483-493
references: 22389648
references: Cancer Res. 2009 Oct 15;69(20):8102-10
references: 19789348
references: Am J Pathol. 2002 Aug;161(2):727-35
references: 12163397
references: Neoplasia. 2008 Mar;10(3):244-54
references: 18320069
references: Prostate. 2014 Nov;74(15):1481-7
references: 25175352